News

January 27, 2020

Single Use Support interview with CHEManager

micheal-eder
Michael Eder

The managing directors of Single Use Support, Thomas Wurm and Johannes Kirchmair, are interviewed by Birgit Megges from CHEManager. What they say about the original business idea, opportunities and difficulties is here!
 

December 11, 2019

Single Use Support awarded at Young Entrepreneurs Award 2019

micheal-eder
Michael Eder

Single Use Support wins the Young Entrepreneur Competition of the business magazine Gewinn in the category Export. In the overall ranking, Single Use Support made it to fifth place out of 100. Click here for the full article!
 

October 30, 2019

Freeze-thaw platform revolutionizing the drug substance logistics process

micheal-eder
Michael Eder

With bulk drug substances playing an increasingly important role in the pharmaceutical and biopharmaceutical industry, the need for a reliable freeze/thaw process as well as safe shipping and storage is more important than ever.
 

August 28, 2019

Are single use technologies ecologically harmful? Correct disposal and recycling

micheal-eder
Michael Eder

Due to the use of disposable systems, which are disposed of after use, single use technologies appear at first glance to be a major environmental burden. How it looks like in reality, you can find out here!

August 26, 2019

Single Use Support enters US market

micheal-eder
Michael Eder

Single Use Support’s US office opens its doors on May 1st in Boston, Massachusetts. Our office manager in Boston will be the ideal go-to person for all local customers.
 

August 2, 2019

Single-use vs. stainless steel technology in biopharma

micheal-eder
Michael Eder

It is not always easy to decide whether to utilize single use systems or stainless steel devices for the production of biopharmaceuticals. Find out about the differences between single use technology and stainless steel reactors in terms of safety, costs, use of energy, efficiency and more – in this article.

July 11, 2019

Start small but think big & endless scalability all the way from the lab to blockbuster level!

micheal-eder
Michael Eder

There is no doubt that single use systems are going to be part of any future production strategies put in place by the biopharma industry. Why Susupport can be the solution you can read in here!
 

June 6, 2019

Bulk drug substance logistic with single use technology

micheal-eder
Michael Eder

It is not easy to choose the right technology when it comes to developing biopharmaceutical drug products! It’s important for frozen storage and transport solutions to be safe and cost-effective at the same time, especially as drugs transition from R&D through clinical trial and to higher volume production.
 

May 21, 2019

Super-fast, Agile and Modular Single Use Filling System for the Biopharma Industry

micheal-eder
Michael Eder

The fill and drain process for biopharmaceutical products can be a massive challenge for the biopharma industry. Here, single use systems offer a multitude of advantages.

May 14, 2019

Now available: Freeze-thaw platform for rent

micheal-eder
Michael Eder

Test our RoSS.pFTU lab scale – the perfect freeze and thaw technology for single use bags that is completely standalone, meaning it is compatible with any established bag brand. You can rent our freeze-thaw platform for up to three months. You will be reimbursed for the rent paid if you choose to purchase the platform.

April 18, 2019

Single use bags are not perfect: How you can make sure they are nonetheless 100% safe to use

micheal-eder
Michael Eder

We at Single Use Support have found a solution to use the Single Use Bag with all its weak points completely safely. But how can the risk of losing valuable drug substance towards zero be minimized?

April 9, 2019

How to avoid mistakes during the filling process for cell and gene therapies and make sure that no human life is at risk

micheal-eder
Michael Eder

Autologous therapies are therapies that are derived from the patient and as such they exhibit certain specific requirements. The scope of such therapies differs greatly from what we usually see in the biopharma industry, and they require special handling and care. The quantities are much smaller than usual, but nonetheless they need to be shipped in a highly sterile and protected manner.